PALISADE CAPITAL MANAGEMENT, LP - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 49 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
PALISADE CAPITAL MANAGEMENT, LP ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$6,226,110
+1.7%
6,270,0000.0%0.17%
+2.4%
Q4 2022$6,121,088
+0.2%
6,270,000
-0.2%
0.16%
-5.2%
Q3 2022$6,110,000
+5.7%
6,283,000
+5.6%
0.17%
+10.2%
Q2 2022$5,782,000
-41.2%
5,952,000
-40.5%
0.16%
-30.5%
Q1 2022$9,832,000
-0.5%
10,006,000
+1.8%
0.23%
+13.0%
Q4 2021$9,883,000
+3.6%
9,833,000
+3.5%
0.20%
-3.8%
Q3 2021$9,536,000
+76.6%
9,501,000
+73.9%
0.21%
+70.5%
Q2 2021$5,399,000
+11.9%
5,464,000
+16.9%
0.12%
+8.0%
Q1 2021$4,825,000
-19.4%
4,675,000
-25.9%
0.11%
-26.1%
Q4 2020$5,989,000
-47.4%
6,311,000
-49.8%
0.15%
-54.7%
Q3 2020$11,396,000
+32.5%
12,569,000
+27.3%
0.34%
+23.8%
Q2 2020$8,598,000
+17.2%
9,875,000
+11.3%
0.27%
+5.4%
Q1 2020$7,338,000
-4.5%
8,875,0000.0%0.26%
+18.8%
Q4 2019$7,682,000
+3.5%
8,875,0000.0%0.22%
-4.0%
Q3 2019$7,420,000
-3.1%
8,875,0000.0%0.23%
-3.8%
Q2 2019$7,655,0008,875,0000.24%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
CANYON CAPITAL ADVISORS LLC 40,000,000$38,988,0001.44%
Penn Mutual Asset Management, LLC 1,204,000$1,174,0001.36%
TFG Asset Management GP Ltd 21,600,000$21,148,0000.96%
PALISADE CAPITAL MANAGEMENT, LP 10,006,000$9,832,0000.23%
TENOR CAPITAL MANAGEMENT Co., L.P. 11,645,000$11,431,0000.22%
OAKTREE CAPITAL MANAGEMENT LP 20,353,000$19,882,0000.21%
Wellesley Asset Management 2,304$2,245,0000.15%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 10,000,000$9,719,0000.12%
SSI INVESTMENT MANAGEMENT LLC 2,000,000$1,942,0000.11%
Cutler Capital Management, LLC 300,000$291,0000.10%
View complete list of LIGAND PHARMACEUTICALS INC shareholders